Day: March 6, 2025
MIAMI, March 06, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, is reporting financial results for the fourth quarter and full year ended December 31, 2024. Unless otherwise noted, all results are presented in U.S. dollars.
Steven M. Cohen, Interim CEO of AYR, said, “Over the past quarter we have made crucial steps towards reorienting the business to reflect our forward-looking vision of AYR. And while our fourth quarter and full year results reflected ongoing macroeconomic pressures and company-specific challenges that impacted revenue and profitability, we remain confident that sustained growth and enhanced profitability are achievable within our footprint through disciplined cost reductions, streamlined operations,...
Xunlei Limited Schedules 2024 Unaudited Fourth Quarter and Fiscal Year Earnings Release on March 13, 2025
Written by Customer Service on . Posted in Public Companies.
SHENZHEN, China, March 06, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024 on March 13, 2025 before market open.
The earnings press release will be available on the Company’s investor relations page at http://ir.xunlei.com.
Conference Call
Xunlei’s management will host a conference call at 8:00 a.m. U.S. Eastern Time on March 13, 2025 (8:00 p.m. Beijing/Hong Kong Time), to discuss the Company’s quarterly and fiscal year results and recent business developments.
Conference Call Preregistration
Participant Online Registration: https://register.vevent.com/register/BI571290b28e04470f8c18382c10e6680e
Please...
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
Written by Customer Service on . Posted in Public Companies.
LONDON, March 06, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2024 financial results and operational highlights before open of US markets on Thursday, March 20, 2025.
Management will host a conference call and webcast at 8:30 am EDT/12:30 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.
A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.
About Autolus...
Conavi Medical Announces Uplisting to OTCQB Venture Market
Written by Customer Service on . Posted in Public Companies.
– Expected to enhance visibility and access to U.S. investors
– Trading to commence on March 6, 2025
TORONTO, March 06, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its common shares have been approved for uplisting from the OTC Pink Open Market to the OTCQB Venture Market, with trading set to commence on March 6, 2025. The ticker symbol will remain CNVIF, and no action is needed by shareholders. Trading on the OTCQB is expected to complement the Company’s existing listing on the TSX Venture Exchange.
“As we move toward commercial launch of our next-generation...
Questor Announces Sale of Clean Combustion Solution
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, March 06, 2025 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor”, the “Company”), (TSX Venture Exchange: QST) announced today a $0.9 million purchase order to supply a clean combustion solution to manage a variety of railcar vapours at a Caltrax Inc. full-service railcar repair and maintenance facility in Calgary.
Questor’s partnership with Caltrax highlights the versatility of Questor’s clean combustion units, used in this application to safely and cleanly combust hydrocarbon vapours in urban settings, such as Calgary. Questor’s ISO 14034-certified clean combustion units are engineered to safely manage rail car vapours through a variety of waste gas compositions, eliminating methane and other harmful pollutants at a 99.99% combustion efficiency. These units meet and exceed the most stringent global emissions...
Rego Payment Architectures, Inc. Announces Its White-Label Senior Financial Management Product To Be Available End of March 2025
Written by Customer Service on . Posted in Public Companies.
Financial institutions will be able to launch banking products in their own brand that provide oversight and insight into elderly financial health to their caretakers
BLUE BELL, Pa., March 06, 2025 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), the leading white-label family financial lifecycle solution platform, today announced the upcoming launch of a first-of-its-kind white-labeled senior financial management (SFM) product that enables banks and credit unions to help protect the financial well-being of senior citizens. REGO’s SFM product allows financial institutions to deploy an integrated branded solution that provides caretakers and fiduciaries with critical oversight and insight into their loved ones’ financial activity and help guard against fraud – even if they bank at different institutions.
Financial...
HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements
Written by Customer Service on . Posted in Public Companies.
MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported that, on March 3, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”) granted the Company an extension in which to regain compliance with all continued listing rules of The Nasdaq Capital Market.
The Panel’s determination follows a hearing on February 13, 2025, at which the Panel considered the Company’s plan to regain compliance with Listing Rules 5450(a)(1), 5450(b)(2)(A) and 5450(b)(2&3)(C), the minimum bid price (“Bid Price”), the market value...
IREN February 2025 Monthly Update
Written by Customer Service on . Posted in Public Companies.
SYDNEY, March 06, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for February 2025.
February HighlightsResilient mining hardware profit margin (70%)
Ramping up to 50 EH/s over the next 4 months
AI Cloud Service nearing full utilization at end of Feb
AI Data Center ‘Horizon 1’ customer diligence ongoing
Commenced site-works at 1.4GW Sweetwater 1 project, on-track for energization in Apr 2026
Finalizing 600MW Sweetwater 2 connection agreementKey Metrics
Feb 25*
Jan 25
Dec 24Bitcoin Mining
Average operating hashrate
28.7 EH/s
29.0 EH/s
28.1 EH/sBitcoin mined3
459 BTC
521 BTC
529 BTCRevenue (per Bitcoin)
$95,570
$99,789
$98,524Electricity cost (per Bitcoin)1
($28,341)
($24,683)
($22,799)Revenue
$43.9m
$52.0m
$52.1mElectricity...
Burlington Stores, Inc. Reports Fourth Quarter and Full Year 2024 Earnings
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Q4 comparable store sales growth of 6%, versus guidance of 0% to 2%
Q4 net income was $261 million, and diluted EPS was $4.02
FY24 total sales growth of 11% and comparable store sales growth of 4%
FY24 net income was $504 million, and diluted EPS was $7.80
Excluding expenses associated with bankruptcy acquired leases:Q4 Adjusted EBIT margin increased 10 basis points
Q4 Adjusted EPS increased 12% to $4.13, versus guidance of $3.55 to $3.75
FY24 Adjusted EBIT margin of 7.2%, an increase of 100 basis points versus FY23
FY24 Adjusted EPS of $8.35, an increase of 34% versus FY23BURLINGTON, N.J., March 06, 2025 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today...
Whitestone REIT Declares Second Quarter 2025 Dividend
Written by Customer Service on . Posted in Dividend Reports And Estimates.
HOUSTON, March 06, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.045 per share on the Company’s common shares and operating partnership units for the second quarter of 2025. The dividend represents a quarterly amount of $0.135 per share, and an annualized amount of $0.54 per share.
The second quarter dividend distribution for 2025 will be as detailed below:Month
Record Date
Payment Date
Distribution per Share/UnitApril
4/1/2025
4/10/2025
$0.045May
5/1/2025
5/13/2025
$0.045June
6/2/2025
6/12/2025
$0.045
About Whitestone REIT
Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air, retail centers...